Panagiotis Katsaounis

Founder & CEO

Metabio

Thessaloniki, Macedonia, Greece

4 profile visits

MSc, Medical Molecular Genetics. Expertise in: Cancer Genetics, Biobanking, Biomarker Diagnostics, with strong commercial experience at international level.

My organisation

Metabio

SME

Thessaloniki, Greece

Metabio multi-award-winning Private Company is an innovative biotech company, based in Thessaloniki, Greece with subsidiaries based in Sofia, Bulgaria and Delaware, USA. Metabio designs, provides and implements novel IT solutions for the Life science sector with a strong focus in the human biosample usage chain. The company addresses the current and future needs in the life science industry, by providing a spectrum of "smart" information systems and solutions, from consultancy services for the creation of Next Generation Biobanks, technology to the life science sector and healthcare systems, by establishing patient-centered strategies and methodologies of operation for the entire value chain; thus, upgrading associated networks’ value and simultaneous advances in research. In all of Metabio’s solutions, the patient is the focal point of the IT architecture and the system’s value proposition. This patient-centric approach sets Metabio in a mission to democratize the Biobanking sector and research upon biosamples. Metabio innovates biosample annotation, raises scientific and market value of biosamples, optimizes the drug developmental cycle and provides personalized medicine tools. By addressing current IT systems’ fragmentations, lack of longitudinal data harmonization and standardization, data redundancy, non-interoperability, biospecimen accessibility, real time stock availability and patient involvement. Metabio follows all European regulations, is 100% GDPR complaint, and operates under ISO 9001, ISO 27001 and ISO 90003.

About me

EDUCATION

2005,University of Aberdeen, MSc, Honours with Commendation Medical Molecular Genetics.

2004,University of Aberdeen, BSc, Upper Second Class Honours Genetics

WORK EXPERIENCE

2018-today, Founder and CEO, Metabio PC

2009-2014, Carcer Research, IMF, Aberdeen, Scotland

2007-2008, Assistant Researcher, Gene4U

PUBLICATIONS

Sandra Nanyonga, Plebeian B. Medina, Zisis Kozlakidis, Debra Leiolani Garcia, Desislava Ivanova, and Panagiotis Katsaounis, “Proliferation, Ingestion, and Interpretation of Health Data in Low-and Middle-Income Countries (LMICS), Springer Cham, “Digitalization of Healthcare in Low- and Middle-Income Countries (LMICs): An Overview,” Sustain. Dev. Goals Ser., vol. Part F3373, pp. 1–4, 2024, doi: 10.1007/978-3-031-62332-5_1Series, · Sep 1, 2024

D. Ivanova, P. Katsaounis, and K. Votis, “Increasing the Value of Real- World Crowdsourcing Health Data with e-MetaBio, a Novel Patient- Centric IT Infrastructure,” Innov. Digit. Heal. Diagnostics, Biomarkers, vol.4, no. 2024, pp. 15–24, Jan. 2024, doi: 10.36401/IDDB-23-14.

D. Ivanova and P. Katsaounis, “Workshop Proceedings: Informed Consent in Biobanking–from the Key Barriers, Challenges, and Perceptions to Digital InnovationsISBER Virtual Annual Meeting and Exhibit, May 14–16, 2021,” Innov. Digit. Heal. Diagnostics, Biomarkers, vol. 2, no. 2022, pp. 16–26, Jan. 2022, doi: 10.36401/IDDB-21-07.

Desislava Ivanova, Panagiotis Katsaounis; Real-Time Dynamic Tiered e-Consent: A Novel Tool for Patients' Engagement and Common Ontology System for the Management of Medical Data. Innovations in Digital Health, Diagnostics, and Biomarkers 1 July 2021; 1 (2): 45–49. doi: https://doi.org/10.36401/IDDB-21-01

Panagiotis Katsaounis, Desislava Ivanova: The Need for Patient-Pushed, Real-World Data on Neurodegenerative Diseases A Complex Field Challenged by Unfit Data The Real-World Data Concept. Published in 2021.https://www.biobanking.com/the-need-for-patient-pushed- real- world-data-on-neurodegenerative-diseases/

CoronaBio: Using Crowdsourcing for Biomedical Research on COVID-19 to Manage a Pandemic, Konstantinos Votis; Zisis Kozlakidis; Panagiotis Katsaounis Innovations in Digital Health, Diagnostics, and Biomarkers (2021) 1 (1): 21–24

Precision medicine is forcing modern biobanks to shift their focus from sample-driven to data-driven strategies, the IARC’s Zisis Kozlakidis tells Health Europa. Zisis Kozlakidis, International Agency for Research and Cancer (WHO), Panagiotis Katsaounis, Metabio, Health Europa, issue 9, 8th March 2019

Social media

Additional questions

Areas od activity

Health innovation Digital health

Organization type

SME